In general, IV bisphosphonates are very well tolerated, and patients rarely require dose modification. In the comparative phase 3 trial of zoledronic acid and pamidronate in patients with breast ...
“In the present study, we used multiple complementary approaches to evaluate the possible effects of zoledronic acid on cellular senescence.” Zoledronic acid has been found to reduce fracture risk and ...
Oral vinorelbine (NVBO) and gemcitabine (GEM) in elderly patients with advanced non-small-cell lung cancer (NSCLC): A phase II study conducted by the Galician Lung Cancer Group (GLCG) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results